GMO's Quality + Value Framework for US Stocks | Kim Mayer, GMO
from Behind the Ticker Hosted by Brad Roth
In this episode of "Behind the Ticker," host Brad interviews Kim Mayer from GMO. Kim has been with GMO for over 18 years, starting his career on the sell side at Morgan Stanley before transitioning to the buy side. He currently holds a dual role at GMO as a portfolio strategist and covers several sectors including luxury goods, beer, spirits, and retail. Kim discusses the launch of GMO's QLTY ETF, which marks GMO's strategic entry into the ETF market. He explains how the ETF aims to make high-quality investment strategies accessible to a broader audience through a focus on U.S. equities. The approach combines both qualitative and quantitative methods to ensure a robust selection process that emphasizes quality and proper valuation. The episode also delves into Kim's personal interests, highlighting his love for activities on water, reflecting his move from New York to Boston. Overall, the podcast provides insights into GMO's investment philosophy and operational strategies, as well as offering a glimpse into the personal life of one of its key figures. Get Brad's daily market research: Subscribe to The Signal at thorft.com/newsletter More episodes: thorft.com/podcast Want the framework behind this conversation? Fifteen minutes with Brad Roth, founder and CIO of THOR: https://thorft.com/call?s=podcast Behind the Ticker — new episode every week. Listen: Spotify · Apple Podcasts · YouTube Episode notes and the full archive: thorft.com/podcast Daily market note, The Signal: thesignal.thorft.com
Embed this episode
What this episode covers
In this episode of "Behind the Ticker," host Brad interviews Kim Mayer from GMO. Kim has been with GMO for over 18 years, starting his career on the sell side at Morgan Stanley before transitioning to the buy side. He currently holds a dual role at GMO as a portfolio strategist and covers several sectors including luxury goods, beer, spirits, and retail. Kim discusses the launch of GMO's QLTY ETF, which marks GMO's strategic entry into the ETF market. He explains how the ETF aims to make high...
No transcript yet.